BioNexus Gene Lab Corp
As of Oct 22, 2026, BioNexus Gene Lab is in Stage 4, the downtrend phase, now in week 39 (since Jan 14, 2026). It closed at $1.19, 78.3% below its 52-week high and below its 200-day average, which is falling.
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electron… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is BGLC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
BGLC among Specialty Chemicals58th of 62 by relative strength
All 62 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | SSL | Stage 2 · wk 7 | 98 | +22.2% |
| 2 | ALTO | Stage 4 · wk 4 | 98 | −3.8% |
| 3 | CLMT | Stage 2 · wk 58 | 97 | −9.3% |
| 4 | KRO | Stage 2 · wk 10 | 90 | −9.4% |
| 5 | LYB | Stage 2 · wk 7 | 87 | +9.0% |
| 6 | ASH | Stage 2 · wk 20 | 86 | +6.6% |
| 7 | IFF | Stage 2 · wk 21 | 85 | +9.5% |
| 8 | KOP | Stage 3 · wk 4 | 85 | −11.9% |
| …58 | BGLC | Stage 4 · wk 39 | 12 | −19.0% |
BioNexus Gene Lab: quick answers
What stage is BioNexus Gene Lab in?
As of Oct 22, 2026, BioNexus Gene Lab (BGLC) is in Stage 4, the downtrend phase. It entered Stage 4 on Jan 14, 2026 and is in week 39. What the four stages mean
Is BioNexus Gene Lab in an uptrend?
No. BioNexus Gene Lab is in a Stage 4 downtrend. It trades 41.8% below its 200-day average, which is falling.
How far is BioNexus Gene Lab from its 52-week high?
BioNexus Gene Lab closed at $1.19 on Oct 22, 2026, 78.3% below its 52-week high of $5.48. Its 52-week low is $1.19.
How has BioNexus Gene Lab performed over the past year?
As of Oct 22, 2026, BioNexus Gene Lab is down 77.1% over the past year and down 69.8% so far in 2026.
Which sector and industry is BioNexus Gene Lab in?
BioNexus Gene Lab is in the Specialty Chemicals industry, part of the Materials sector.
About this companyMaterials· Specialty Chemicals
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.